Jiewei Chen

1.9k total citations · 1 hit paper
44 papers, 1.3k citations indexed

About

Jiewei Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiewei Chen has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Jiewei Chen's work include RNA modifications and cancer (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and MicroRNA in disease regulation (5 papers). Jiewei Chen is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and MicroRNA in disease regulation (5 papers). Jiewei Chen collaborates with scholars based in China, Hong Kong and Germany. Jiewei Chen's co-authors include Dan Xie, Feng‐Wei Wang, Xin‐Yuan Guan, Rixin Chen, Kai Han, Zhizhong Pan, Liangping Xia, Feng Wang, Jing‐Ping Yun and Olivier Déas and has published in prestigious journals such as Nature Communications, Nature Cell Biology and Oncogene.

In The Last Decade

Jiewei Chen

40 papers receiving 1.3k citations

Hit Papers

N6-methyladenosine modification of circNSUN2 facilitates ... 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
    2019 537 citations Rixin Chen, Zhizhong Pan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiewei Chen China 17 901 603 275 197 146 44 1.3k
Qing‐Mei He China 21 893 1.0× 648 1.1× 287 1.0× 139 0.7× 164 1.1× 44 1.3k
Leilei Liang China 20 832 0.9× 559 0.9× 201 0.7× 177 0.9× 191 1.3× 41 1.1k
Rui‐Xi Hua China 23 1.3k 1.4× 755 1.3× 331 1.2× 179 0.9× 67 0.5× 65 1.7k
Kentaro Jingushi Japan 19 930 1.0× 616 1.0× 154 0.6× 151 0.8× 88 0.6× 45 1.1k
Shanzhou� Huang China 18 915 1.0× 591 1.0× 375 1.4× 298 1.5× 146 1.0× 69 1.4k
Cheng Zhou China 17 583 0.6× 436 0.7× 250 0.9× 145 0.7× 179 1.2× 51 1.1k
Jinhuan Wei China 19 883 1.0× 701 1.2× 268 1.0× 330 1.7× 81 0.6× 44 1.4k
Fengkai Xu China 17 645 0.7× 319 0.5× 246 0.9× 199 1.0× 171 1.2× 35 983
Chengli Du China 17 719 0.8× 509 0.8× 236 0.9× 143 0.7× 79 0.5× 32 1.0k

Countries citing papers authored by Jiewei Chen

Since Specialization
Citations

This map shows the geographic impact of Jiewei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewei Chen more than expected).

Fields of papers citing papers by Jiewei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiewei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewei Chen. The network helps show where Jiewei Chen may publish in the future.

Co-authorship network of co-authors of Jiewei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jiewei Chen. A scholar is included among the top collaborators of Jiewei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiewei Chen. Jiewei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chen, Rixin, Minhua Deng, Jiewei Chen, et al.. (2024). Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy. Signal Transduction and Targeted Therapy. 9(1). 80–80. 13 indexed citations
4.
Ma, Xiaodan, Li Xu, Jingdun Xie, et al.. (2024). Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma. Drug Resistance Updates. 73. 101052–101052. 31 indexed citations
5.
Yue, Caifeng, Chang Wang, Jiewei Chen, et al.. (2023). TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. 114(8). 3176–3189. 6 indexed citations
6.
7.
Du, Tian, Lu Pan, Chengyou Zheng, et al.. (2022). Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin. Breast Cancer Research. 24(1). 70–70. 13 indexed citations
8.
Sui, Qiaoqi, Dingxin Liu, Jiang Wu, et al.. (2021). Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer. Journal for ImmunoTherapy of Cancer. 9(3). e001498–e001498. 43 indexed citations
9.
Chen, Zequn, Yutong Liang, Yuehua Liao, et al.. (2021). Cleavage factor Im 25 as a potential biomarker for prognosis of colorectal cancer. Translational Cancer Research. 10(12). 5267–5279. 3 indexed citations
10.
Sun, Xiaoqi, et al.. (2021). Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines. Mathematical Biosciences & Engineering. 18(5). 6262–6287. 16 indexed citations
11.
Duan, Jin‐Ling, Run‐Cong Nie, Jiewei Chen, et al.. (2021). Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications. Journal of Hepatocellular Carcinoma. Volume 8. 493–505. 5 indexed citations
12.
Chen, Li, Xiaohan Jin, Jie Luo, et al.. (2021). ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma. Oncogene. 40(40). 5925–5937. 16 indexed citations
13.
Li, Shuman, Jie Zhou, Yun Wang, et al.. (2020). Recent Findings in the Posttranslational Modifications of PD-L1. Journal of Oncology. 2020. 1–7. 17 indexed citations
14.
Zhang, Chi, Wei Shi, Weipeng Sun, et al.. (2020). Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma. Theranostics. 10(20). 9066–9082. 37 indexed citations
15.
Chen, Jiewei, et al.. (2020). RING finger protein 187 as a novel potential biomarker for predicting the prognosis of ovarian carcinoma in 2 cancer centers. Current Problems in Cancer. 44(5). 100555–100555. 5 indexed citations
16.
Chen, Jiewei, Jun Liu, Xiaoting Chen, et al.. (2019). <p>Low expression of ZMYND8 correlates with aggressive features and poor prognosis in nasopharyngeal carcinoma</p>. Cancer Management and Research. Volume 11. 7835–7843. 7 indexed citations
17.
Chen, Jiewei, et al.. (2018). Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 441–448. 15 indexed citations
18.
Chen, Jiewei, Qing‐Mei He, Jun Liu, et al.. (2018). CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer. Cancer Management and Research. Volume 10. 3505–3511. 30 indexed citations
19.
Chen, Jiewei, Shuman Li, Xuan Zou, et al.. (2017). p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma. BMC Cancer. 17(1). 846–846. 10 indexed citations
20.
Wang, Wei, Sharvesh Raj Seeruttun, Cheng Fang, et al.. (2015). Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients. Annals of Surgical Oncology. 23(4). 1244–1251. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing‐Mei He Breakdown of academic impact, for papers by Leilei Liang Breakdown of academic impact, for papers by Rui‐Xi Hua Breakdown of academic impact, for papers by Kentaro Jingushi Breakdown of academic impact, for papers by Shanzhou� Huang Breakdown of academic impact, for papers by Cheng Zhou Breakdown of academic impact, for papers by Jinhuan Wei Breakdown of academic impact, for papers by Fengkai Xu Breakdown of academic impact, for papers by Chengli Du
Rankless by CCL
2026